Medical Xpress November 29, 2024
Mona Bafadhel, Richard Russell and Sanjay Ramakrishnan, The Conversation

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged—treatment with steroids, such as prednisolone.

Unfortunately, these drugs don’t work for everyone and they have significant levels of serious side-effects. Nearly one-third of patients treated with steroids will see their symptoms worsen again within a month, requiring more treatment and increasing the risk of side-effects.

But what if there was a better option?

Our latest study, published in The Lancet Respiratory Medicine, has revealed that a drug called benralizumab—administered as an injection—may be the breakthrough that we have been waiting for. The results suggest that this...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Provider, Survey / Study, Trends
Congressional spending plan: What’s in it for healthcare, and what isn’t
How 3 hospitals are reimagining behavioral crisis care
How Health Systems Can Collaborate on AI Tools
Critical access hospitals face uphill battle: 6 things to know
AdventHealth's plans for new Florida hospital move forward

Share This Article